The sensitivity of high-resolution CT in detecting idiopathic pulmonary fibrosis proved by open lung biopsy. A prospective study. 1995

J B Orens, and E A Kazerooni, and F J Martinez, and J L Curtis, and B H Gross, and A Flint, and J P Lynch
Department of Internal Medicine, University of Michigan School of Medicine, Ann Arbor, USA.

OBJECTIVE To assess the sensitivity of high-resolution chest computed tomography (HRCT) in detecting idiopathic pulmonary fibrosis proved by biopsy specimen. To determine the degree of physiologic and pathologic abnormalities in patients with idiopathic pulmonary fibrosis who have a false-negative HRCT. METHODS Prospective 2-year study. METHODS Tertiary care university hospital. METHODS All patients with dyspnea and suspected interstitial lung disease referred to the University of Michigan for enrollment in the Idiopathic Pulmonary Fibrosis Specialized Center of Research (SCOR) protocol were included; 25 underwent open lung biopsy and formed the final study group. METHODS All patients underwent physiologic (pulmonary function, gas exchange, and exercise testing), radiologic (chest x-ray film and HRCT), and pathologic assessments (bronchoscopic and open lung biopsy). The results of HRCT were prospectively compared with results of standard pulmonary function tests, cardiopulmonary exercise testing, and open lung biopsy. RESULTS Of 25 patients who had both HRCT and open lung biopsy, 3 patients (12%) had HRCTs that demonstrated no evidence of interstitial lung disease. These three patients had less severe disease based on clinical, radiographic, and physiologic (CRP) scores, gas exchange abnormalities, and pathologic scoring of open lung biopsy specimens, compared with those with an abnormal HRCT. CONCLUSIONS We conclude that in the evaluation of patients with dyspnea and abnormal results of pulmonary function studies, a normal HRCT does not exclude early and clinically significant interstitial lung disease. In our patient population, physiologic testing was more sensitive than HRCT in detecting mild abnormalities in patients with idiopathic pulmonary fibrosis proved by biopsy specimen.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D011658 Pulmonary Fibrosis A process in which normal lung tissues are progressively replaced by FIBROBLASTS and COLLAGEN causing an irreversible loss of the ability to transfer oxygen into the bloodstream via PULMONARY ALVEOLI. Patients show progressive DYSPNEA finally resulting in death. Alveolitis, Fibrosing,Idiopathic Diffuse Interstitial Pulmonary Fibrosis,Fibroses, Pulmonary,Fibrosis, Pulmonary,Pulmonary Fibroses,Alveolitides, Fibrosing,Fibrosing Alveolitides,Fibrosing Alveolitis
D012129 Respiratory Function Tests Measurement of the various processes involved in the act of respiration: inspiration, expiration, oxygen and carbon dioxide exchange, lung volume and compliance, etc. Lung Function Tests,Pulmonary Function Tests,Function Test, Pulmonary,Function Tests, Pulmonary,Pulmonary Function Test,Test, Pulmonary Function,Tests, Pulmonary Function,Function Test, Lung,Function Test, Respiratory,Function Tests, Lung,Function Tests, Respiratory,Lung Function Test,Respiratory Function Test,Test, Lung Function,Test, Respiratory Function,Tests, Lung Function,Tests, Respiratory Function
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D001706 Biopsy Removal and pathologic examination of specimens from the living body. Biopsies

Related Publications

J B Orens, and E A Kazerooni, and F J Martinez, and J L Curtis, and B H Gross, and A Flint, and J P Lynch
March 2010, Radiology,
J B Orens, and E A Kazerooni, and F J Martinez, and J L Curtis, and B H Gross, and A Flint, and J P Lynch
July 2003, AJR. American journal of roentgenology,
J B Orens, and E A Kazerooni, and F J Martinez, and J L Curtis, and B H Gross, and A Flint, and J P Lynch
December 2005, AJR. American journal of roentgenology,
J B Orens, and E A Kazerooni, and F J Martinez, and J L Curtis, and B H Gross, and A Flint, and J P Lynch
May 2014, The Lancet. Respiratory medicine,
J B Orens, and E A Kazerooni, and F J Martinez, and J L Curtis, and B H Gross, and A Flint, and J P Lynch
December 2017, Kardiochirurgia i torakochirurgia polska = Polish journal of cardio-thoracic surgery,
J B Orens, and E A Kazerooni, and F J Martinez, and J L Curtis, and B H Gross, and A Flint, and J P Lynch
May 2014, The Lancet. Respiratory medicine,
J B Orens, and E A Kazerooni, and F J Martinez, and J L Curtis, and B H Gross, and A Flint, and J P Lynch
January 2016, Respiration; international review of thoracic diseases,
J B Orens, and E A Kazerooni, and F J Martinez, and J L Curtis, and B H Gross, and A Flint, and J P Lynch
January 2002, Pathology, research and practice,
J B Orens, and E A Kazerooni, and F J Martinez, and J L Curtis, and B H Gross, and A Flint, and J P Lynch
January 2012, European radiology,
J B Orens, and E A Kazerooni, and F J Martinez, and J L Curtis, and B H Gross, and A Flint, and J P Lynch
January 2016, Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG,
Copied contents to your clipboard!